Menu

Blog

Aug 24, 2020

Genetic Variants May Explain High Levels of Antibodies Against Epstein-Barr Virus in MS, Study Suggests

Posted by in categories: biotech/medical, genetics, neuroscience

Genetic variants may contribute to increased levels of antibodies against proteins of the Epstein-Barr virus — a known environmental risk factor for multiple sclerosis (MS) — in MS patients and their siblings, a study suggests.

The study, “EBNA-1 titer gradient in families with multiple sclerosis indicates a genetic contribution,” was published in the journal Neurology, Neuroimmunology and Neuroinflammation.

Leave a reply